Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
XBI
XBI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XBI News
Major Test for the IPO Market This Week as Multiple Unicorns Prepare to Launch.
Feb 03 2026
Barron's
IBRX Stock Gains Retail Enthusiasm Following Saudi FDA Approval of Company's Bladder Cancer Immunotherapy
Jan 14 2026
stocktwits
Moderna Stock's Strong Performance is Just the Start: A Technical Analysis
Jan 13 2026
Barron's
'Biotech Super Bowl' Fizzles as Stocks Drop Amid Absence of Deal Announcements.
Jan 12 2026
Barron's
Biotech and Pharma Shares Drop as Investors Shift Focus to Energy Sector
Jan 05 2026
Barron's
UnitedHealth Focuses on Recovery Alongside Four Key Healthcare Stock Trends to Monitor in 2026
Dec 28 2025
Barron's
Mergers and Acquisitions Reached New Heights This Year: Stocks Poised for Greater Growth in 2026.
Dec 23 2025
Barron's
State Street® SPDR® S&P® Biotech ETF announces dividend of $0.4066
Dec 22 2025
SeekingAlpha
ETF Outflow Warning: XBI, EXAS, RVMD, RNA
Dec 11 2025
NASDAQ.COM
Eight Stock Selections to Capitalize on a Robust Sector of the Market
Dec 11 2025
MarketWatch
The Fed Reduced Interest Rates, But Biotech Remained Unaffected.
Dec 10 2025
MarketWatch
Biotech ETF (XBI) Reaches Record 52-Week Peak
Dec 05 2025
NASDAQ.COM
Former FDA Leaders Push Back Against Recent Changes at the Agency
Dec 04 2025
Barron's
The Biotech Sector Is Stronger Than Investors Realize: Key Stocks to Monitor.
Dec 04 2025
Barron's
Introducing the Latest AI Champions: Alphabet, Tesla, Major Pharmaceutical Companies, and Biotech Firms
Dec 03 2025
Barron's
Significant ETF Inflows: XBI, EXAS, RVMD, RNA
Dec 03 2025
NASDAQ.COM
Show More News
